MACROGENICS INC Logo

MACROGENICS INC

A biopharmaceutical company developing antibody-based therapeutics for cancer.

MGNX | US

Overview

Corporate Details

ISIN(s):
US5560991094
LEI:
Country:
United States of America
Address:
9704 MEDICAL CENTER DRIVE, 20850 Rockville

Description

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The company utilizes its proprietary antibody engineering platforms, including the DART (Dual-Affinity Re-Targeting) and TRIDENT technologies, to create novel product candidates. Its pipeline consists of investigational treatments such as monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific antibodies. MacroGenics maintains fully-integrated capabilities, from research and discovery through to GMP (Good Manufacturing Practice) manufacturing, to advance its portfolio of potential medicines for patients with unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 21:31 English 7.1 KB
2025-05-13 22:02
8-K
English 271.5 KB
2025-05-13 22:01
10-Q
English 1.1 MB
2025-04-17 22:00 English 11.0 KB
2025-04-11 22:01
DEFA14A
English 2.0 MB
2025-04-11 22:00
DEF 14A
English 5.5 MB
2025-03-20 21:05
8-K
English 277.6 KB
2025-03-20 21:05
10-K
English 3.3 MB
2025-02-26 23:11
8-K
English 64.7 KB
2025-02-19 22:31
FORM 4
English 7.0 KB
2025-02-19 22:29
FORM 4
English 7.2 KB
2025-02-19 22:28
FORM 4
English 7.0 KB
2025-02-19 22:25
FORM 4
English 7.1 KB
2025-02-19 22:24
FORM 4
English 7.1 KB
2025-02-19 22:23
FORM 4
English 7.1 KB

Automate Your Workflow. Get a real-time feed of all MACROGENICS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MACROGENICS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MACROGENICS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Chong Kun Dang Pharmaceutical Corp. Logo
Develops and manufactures drugs for systemic anti-infectives and metabolic diseases.
South Korea
185750
CHOONG ANG VACCINE LABORATORY Logo
Develops and manufactures vaccines, pharmaceuticals, and feed additives for animals.
South Korea
072020
CHOSA Oncology AB Logo
Develops diagnostics and therapeutics for platinum-based chemotherapy.
Sweden
CHOSA
CHUGAI PHARMACEUTICAL CO., LTD. Logo
A research-driven pharmaceutical company developing innovative medical products.
Japan
4519
CHUKYOIYAKUHIN CO.,LTD. Logo
Offers health products and pharmaceuticals via a direct-to-home placement service.
Japan
4558
Cidara Therapeutics, Inc. Logo
Develops targeted immunotherapies and anti-infectives for serious diseases.
United States of America
CDTX
Cinclus Pharma Holding AB Logo
Clinical-stage pharma company developing a PCAB for gastric acid-related diseases.
Sweden
CINPHA
Cingulate Inc. Logo
A clinical-stage biopharma firm developing treatments for ADHD and anxiety.
United States of America
CING
CITIUS ONCOLOGY, INC. Logo
Biopharmaceutical company developing and commercializing targeted oncology therapies.
United States of America
CTOR
Citius Pharmaceuticals, Inc. Logo
A late-stage biopharmaceutical company developing and commercializing critical care products.
United States of America
CTXR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.